SCOPUS 정보 검색 플랫폼

European Journal of Cancer

Volumn 36, Issue SUPPL. 4, 2000, Pages 81-82

Clinico-pharmacological aspects of different hormone treatments

(1) Lonning, P E a

a HAUKELAND UNIVERSITY HOSPITAL (Norway)

Author keywords

Breast cancer; Drugs; Endocrine therapy

Indexed keywords

AMINOGLUTETHIMIDE; ANASTROZOLE; ANTIESTROGEN; ANTINEOPLASTIC AGENT; AROMATASE; AROMATASE INHIBITOR; EXEMESTANE; LETROZOLE; TAMOXIFEN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER HORMONE THERAPY; CLINICAL PHARMACOLOGY; DRUG POTENCY; DRUG SELECTIVITY; ENZYME INHIBITION; HUMAN; PRIORITY JOURNAL;

EID: 0033746297 PISSN: 09598049 EISSN: None Source Type: Journal
DOI: 10.1016/s0959-8049(00)00237-9 Document Type: Article

Times cited : (11)

References (13)

1
- 0032530988
- Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: Results of a survival update based on a combined analysis of data from two mature phase III trials
- (1998) Cancer , vol.83 , pp. 1142-1152
- Buzdar, A.U.¹ Jonat, W.² Howell, A.³

2
- 0031943424
- Letrozole, a new oral aromatase inhibitor for advanced breast cancer: Double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate
- (1998) J Clin Oncol , vol.16 , pp. 453-461
- Dombernowsky, P.¹ Smith, I.² Falkson, G.³

3
- 0000628683
- Survival advantage of exemestane (AromasinR) over megestrol acetate (MA) in postmenopausal women with advanced breast cancer (ABC) refractory to tamoxifen (tamoxifen): Results of a phase III randomized double-blind study
- Abstract 412
- (1999) Proc Am Soc Clin Oncol , vol.18
- Kaufmann, M.¹ Bajetta, E.² Dirix, L.Y.³

4
- 0028861402
- Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer
- (1995) Lancet , vol.345 , pp. 29-30
- Howell, A.¹ DeFriend, D.² Robertson, J.³ Blamey, R.⁴ Walton, P.⁵

5
- 0033013878
- Cross-resistance to different aromatase inhibitors in breast cancer treatment
- (1999) Endocrine Rel Cancer , vol.6 , pp. 251-257
- Lonning, P.E.¹

6
- 0029566969
- Mechanisms of action of endocrine treatment in breast cancer
- (1995) Crit Rev Oncol/Haematol , vol.21 , pp. 158-193
- Lonning, P.E.¹ Lien, E.²

7
- 0032729804
- Multicenter, phase II trial of exemestane as third-line hormonal therapy of postmenopausal women with metastatic breast cancer
- (1999) J Clin Oncol , vol.17 , pp. 3418-3425
- Jones, S.¹ Vogel, C.² Arkhipov, A.³

8
- 0001165728
- Phase I study of a third-generation selective estrogen receptor modulator (SERM3, LY353381.HCl) in refractory, metastatic breast cancer
- Abstract 442
- (1998) Breast Cancer Res Treat , vol.50 , pp. 306
- Hudis, C.¹ Buzdar, A.² Munster, P.³

9
- 0000340802
- High-dose estrogen treatment in postmenopausal patients heavily exposed to endocrine treatment for advanced breast cancer
- Abstract 440
- (1998) Breast Cancer Res Treat , vol.50 , pp. 305
- Lonning, P.E.¹ Anker, G.² Taylor, P.D.³

10
- 0032974114
- Combination hormonal therapy involving aromatase inhibitors in the management of women with breast cancer
- (1999) Endocrine-Rel Cancer , vol.6 , pp. 265-269
- Ingle, J.N.¹ Suman, V.J.² Jordan, V.C.³ Dowsett, M.⁴

11
- 0025133172
- Decreased serum concentrations of tamoxifen and its metabolites induced by aminoglutethimide
- (1990) Cancer Res , vol.50 , pp. 5851-5857
- Lien, E.A.¹ Anker, G.² Lonning, P.E.³ Solheim, E.⁴ Ueland, P.M.⁵

12
- 0032943956
- The effect of anastrozole on the pharmacokinetics of tamoxifen in post-menopausal women with early breast cancer
- (1999) Br J Cancer , vol.79 , pp. 311-315
- Dowsett, M.¹ Tobias, J.S.² Howell, A.³

13
- 0032836573
- Impact of tamoxifen on the pharmacokinetics and endocrine effects of the aromatase inhibitor letrozole in postmenopausal women with breast cancer
- (1999) Clin Cancer Res , vol.5 , pp. 2338-2343
- Dowsett, M.¹ Pfister, C.² Johnston, S.R.D.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.